Study | Year | Population | Disease | Patients MAF(%) (n) | Controls MAF(%) (n) | OR | 95% confidence interval for OR | Association |
---|---|---|---|---|---|---|---|---|
Jacobsen et. al. [20] | 2000 | Germany | MS | 3.2 (219) | 0.0 (189) | NA†| NA†| 1.5 × 10-4 |
Jacobsen et. al. [20] | 2000 | Germany | MS | 3.2 (108) | 0.0 (114) | NA†| NA†| 0.0058 |
Jacobsen et. al. [20] | 2000 | USA | MS | 1.6 (122) | 1.8 (244) | 0.89 | 0.27-2.91 | Not significant |
Jacobsen et. al. [20] | 2000 | Germany | MS | 3.3 (76) | 0.4 (119) | 8.06 | 0.93-69.68 | 0.0342 |
Barcellos et. al. [37] | 2001 | USA | MS | 1.7 (450) | 1.2 (253) | 1.41 | 0.54-3.66 | Not significant |
Vorechovsky et. al. [38] | 2001 | Sweden | MS | 1.5 (630) | 1.4 (1044) | 1.05 | 0.59-1.87 | Not significant |
Vorechovsky et. al. [38] | 2001 | Sweden | CVID | 2.3 (44) | 1.4 (1044) | 1.60 | 0.38-6.78 | Not significant |
Vorechovsky et. al. [38] | 2001 | Sweden | IgAD | 1.4 (148) | 1.4 (1044) | 0.94 | 0.33-2.69 | Not significant |
Vorechovsky et. al. [38] | 2001 | UK | CVID | 1.5 (98) | 0.9 (232) | 1.79 | 0.40-8.06 | Not significant |
Vorechovsky et. al. [38] | 2001 | UK | IgAD | 0.0 (17) | 0.9 (232) | NA†| NA†| Not significant |
Miterski et. al. [39] | 2002 | Germany | MS | 0.8 (454) | 1.4 (347) | 0.53 | 0.20-1.40 | Not significant |
Wood et. al. [40] | 2002 | Germany | TID | 0.2 (228) | 1.3 (196) | 0.17 | 0.02-1.46 | Not significant |
Wood et. al. [40] | 2002 | Germany | Graves | 1.3 (297) | 1.3 (196) | 1.06 | 0.34-3.25 | Not significant |
Ballerini et. al.[27] | 2002 | Italy | MS | 1.0 (194) | 0.0 (222) | NA†| NA†| p = 0.02 |
Gomez-Lira et. al. [30] | 2003 | Italy | MS | 1.2 (448) | 0.9 (529) | 1.30 | 0.55-3.08 | Not significant |
Schwinzer et. al. [31] | 2003 | Germany | SSca | 3.7 (67) | 0.7 (205) | 5.26 | 1.24-22.31 | p = 0.029 |
Schwinzer et. al. [31] | 2003 | Germany | SLE | 2.0 (98) | 0.7 (205) | 2.83 | 0.63-12.75 | Not significant |
Vogel et. al. [32] | 2003 | Germany | AIHb | 3.2 (190) | 0.7 (210) | 4.53 | 1.27-16.19 | p = 0.015 |
Tackenberg et. al. [35] | 2003 | Germany | MG | 0.6 (78) | 0.0 (303) | NA†| NA†| Not significant |
Nicholas et. al. [41] | 2003 | UK | MS | 2.6 (330) | 2.0 (197) | 1.28 | 0.55-2.98 | Not significant |
Thude et. al. [42] | 2004 | Germany | TID | 1.2 (165) | 1.1 (220) | 1.07 | 0.28-4.01 | Not significant |
Cocco et. al.[43] | 2004 | Sardinia | MS | 1.0 (246) | 0.7 (226) | 1.54 | 0.37-6-47 | Not significant |
Vyshkina et. al. [28] | 2004 | USA | MS | NA (176)c | NA (NA) | NA | NA | p = 0.0342d |
Esteghamat et. al. [44] | 2005 | Iran | AIHb | 0.0 (70) | 0.4 (140) | NA†| NA†| Not significant |
Kirsten et. al. [45] | 2008 | Germany | SSca | 0.6 (171) | 1.4 (179) | 0.42 | 0.08-2.16 | Not significant |
Pan-Hammarström et. al.[46] | 2008 | Sweden | IgAD | 1.3 (232) | 1.2 (913) | 1.07 | 0.43-2.66 | Not significant |
Pan-Hammarström et. al.[46] | 2008 | Sweden | CVID | 0.5 (91) | 1.2 (913) | 0.45 | 0.06-3.38 | Not significant |
Szvetko et. al. [34] | 2009 | Australia | MS | 3.2 (155) | 2.3 (171) | 2.25 | 0.76-6.65 | Not significant |